Displaying 1 - 12 items out of 15 results
ILCN article
Regulating Artificial Intelligence
… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN: Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh: FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …
ILCN article
TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research
Collaboration
… for Patients with Lung Cancer and COVID-19 Drives Research Collaboration …
ILCN article
Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says
… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …
ILCN article
Passing of The Baton—On the Death of Patient Research Advocates
… says. … Passing of The Baton—On the Death of Patient Research Advocates … Angus Pratt …
ILCN article
A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc)
… A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc) …
ILCN article
Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams
… Opportunities for Innovative Multidisciplinary Cancer Research Teams …
ILCN article
Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines
… Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines …
ILCN article
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
… of care and limited resources to review applications, researchers say they support the agency’s decision not to …
ILCN article
Pragmatic Approach to Trial Design Born from Lung-MAP Substudy
… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …











